 This retrospective cohort study evaluated the effectiveness and safety of trans-catheter arterial embolization, TAE, as a treatment option for tumor hemorrhage in patients with solid cancers. The results showed that TAE had a high technical success rate, 89.1%, and a good clinical success rate, 84.8%. Additionally, the rate of proximal embolization was low, 10.9%, and there was no significant difference in the rate of complications or mortality between those who received proximal embolization and those who did not. Overall, the study concluded that TAE is a safe and effective treatment option for tumor hemorrhage in patients with solid cancers. This article was authored by Roberto Menesi, Giuseppe Guzardi, Massimo Venturini, and others.